FDA Review Of Potential Ginseng Import Problems Urged by Senate Cmte.
This article was originally published in The Tan Sheet
Executive Summary
FDA should take "swift action" against potentially adulterated imports of ginseng, an accompanying report to the Senate Agriculture appropriations bill (S 1233) states. The bill was passed unanimously by the full Appropriations Committee June 17.